Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces positive new ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana"), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal ...
A study reveals specialized base barrier cells in the choroid plexus that seal off the brain and cerebrospinal fluid. During ...
Central Square Foundation (CSF) hosted the EdTech and AI Convening - Education Dialogues, a satellite event of the India AI ...
Kyntra Bio Inc. KYNB, formerly Fibrogen, shares fluctuated in Tuesday’s premarket session as the company announced data from a Phase 1b/2 study of FG-3246 in combination with enzalutamide for treating ...
The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.
FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, ...
News-Medical.Net on MSN
Study identifies PPP2R5C blood marker that may detect Alzheimer’s disease earlier
By Tarun Sai Lomte Researchers report that declining PPP2R5C levels in blood may signal early Alzheimer’s pathology, offering ...
Custom precision gearboxes enable the controlled, predictable motion required for modern neurosurgery. By stabilising and ...
Yawning reverses cerebrospinal fluid flow, boosts brain blood surge, and may aid cooling and waste movement, challenging the idea that it signals boredom alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results